ALLO-501,allo-501A
allogene therapeutics
['lymphoma', 'allogene therap', '$allo']
$allo allogene therapeutics presents updated allo-501/501a phase 1 data in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting | marketscreener 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities